Insider Shareholders with Direct Ownership of Trans Medics Group, Inc. (TMDX)
This section provides a comprehensive overview of the insiders with direct ownership of Trans Medics Group, Inc. (TMDX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
TransMedics Group, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 393,368 | 0 | 258,676 $20.5 Million | 5 |
May 23, 2024
Added 0.28%
|
|
|
Waleed H Hassanein
President & CEO |
871,703 | 556,130 | 61,643 $4.89 Million | 60 |
Oct 15, 2024
Reduced 0.48%
|
|
Miriam Provost
VP, Global Regulatory Affairs |
43,768 | 20,420 | 23,348 $1.85 Million | 16 |
Dec 15, 2023
Reduced 7.1%
|
|
Stephen Gordon
Chief Financial Officer |
262,405 | 259,677 | 21,299 $1.69 Million | 55 |
Jun 03, 2024
Reduced 8.82%
|
| 34,327 | 13,222 | 21,105 $1.67 Million | 5 |
Aug 27, 2024
Reduced 32.15%
|
|
|
Tamer I Khayal
Chief Commercial Officer |
356,243 | 347,751 | 20,843 $1.65 Million | 94 |
Nov 11, 2024
Reduced 6.54%
|
|
John F Sullivan
VP of Quality & Engineering |
40,417 | 37,217 | 14,273 $1.13 Million | 11 |
Aug 30, 2021
Added 18.31%
|
|
John F Carey
VP of Operations |
81,013 | 71,140 | 14,120 $1.12 Million | 54 |
Feb 01, 2023
Reduced 1.49%
|
| 32,004 | 31,272 | 10,732 $851,476 | 9 |
May 29, 2024
Reduced 10.0%
|
|
| 13,801 | 4,992 | 8,893 $705,570 | 4 |
Aug 07, 2024
Reduced 32.54%
|
|
|
Laura Damme
VP, Clinical Affairs |
16,622 | 10,937 | 5,685 $451,047 | 5 |
Feb 20, 2023
Added 50.0%
|
| 1,925 | 0 | 1,925 $152,729 | 2 |
May 23, 2024
Added 27.55%
|
|
| 1,925 | 0 | 1,925 $152,729 | 2 |
May 23, 2024
Added 27.55%
|
|
| 1,925 | 0 | 1,925 $152,729 | 2 |
May 23, 2024
Added 27.55%
|
|
| 12,482 | 10,557 | 1,925 $152,729 | 6 |
May 23, 2024
Added 27.55%
|
|
| 15,425 | 37,507 | 732 $58,076 | 11 |
Nov 05, 2024
Reduced 66.51%
|